As of 2024-12-12, the Fair Value of Kiniksa Pharmaceuticals Ltd (KNSA) is -1.74 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 21.25 USD, the upside of Kiniksa Pharmaceuticals Ltd is -108.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -161.90 | -161.40 | -157.90 | 183.40 | 14.08 | -56.74 |
| YoY growth | -56.88% | 0.31% | 2.17% | 216.15% | -92.32% | 13.89% |
| Market Cap (mil) | 1,534.25 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | 13.89% |
| TTM earnings | -9.07 |